These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17178072)

  • 1. [Financing smoking cessation treatment through national health systems may improve success].
    de Granda Orive JI; Gutiérrez Jiménez T; Martínez Albiach JM
    Arch Bronconeumol; 2006 Dec; 42(12):666. PubMed ID: 17178072
    [No Abstract]   [Full Text] [Related]  

  • 2. [Smoking cessation as IGeL procedure. Cost effective for physician and patient].
    Hering T
    MMW Fortschr Med; 2002 May; 144(18):52. PubMed ID: 12422709
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coverage of smoking cessation by National Insurance policy].
    Tei C; Yamaguchi A
    J Cardiol; 2006 May; 47(5):267-9. PubMed ID: 16805036
    [No Abstract]   [Full Text] [Related]  

  • 4. [Smoking cessation in general practice. A new program is over 50% effective].
    Hering T; Bölcskei P
    MMW Fortschr Med; 2002 May; 144(18):50-1. PubMed ID: 12422708
    [No Abstract]   [Full Text] [Related]  

  • 5. [The National Action Plan for the Prevention and Control of Smoking Prevention Movement in Spain].
    Villalbí JR
    Rev Esp Salud Publica; 2003; 77(4):435-6. PubMed ID: 12945129
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
    Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
    Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression.
    Barnett PG; Wong W; Hall S
    Addiction; 2008 May; 103(5):834-40. PubMed ID: 18412763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [National Action Plan for Prevention and Tobacco Control].
    Saiz Martínez-Acitores I; Rubio Colavida J; Espiga López I; Alonso de la Iglesia B; Blanco Aguilar J; Cortés Mancha M; Cabrera Ortega JD; Pont Martínez P; Saavedra Rodríguez JM; Toledo Pallarés J
    Rev Esp Salud Publica; 2003; 77(4):441-73. PubMed ID: 12945131
    [No Abstract]   [Full Text] [Related]  

  • 9. Who will pay this tab? New IT cost estimate spurs discussions.
    Conn J
    Mod Healthc; 2005 Aug; 35(32):10-1. PubMed ID: 16117077
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tobacco smoking cessation as covered cost for COPD patients? Therapy goal: smoking cessation without relapse].
    Gross H
    MMW Fortschr Med; 2010 Dec; 152(49-50):12-3. PubMed ID: 21302377
    [No Abstract]   [Full Text] [Related]  

  • 11. [New drugs in Spain -- when are they to be considered cost-effective alternatives and profitable investments for the National Health System? ].
    Soto Alvarez J
    Farm Hosp; 2004; 28(4):299-304. PubMed ID: 15369442
    [No Abstract]   [Full Text] [Related]  

  • 12. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
    Bolin K; Mörk AC; Willers S; Lindgren B
    Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
    Boyd KA; Briggs AH
    Addiction; 2009 Feb; 104(2):317-25. PubMed ID: 19149829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
    Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in preferences for smoking cessation.
    Paterson RW; Boyle KJ; Parmeter CF; Neumann JE; De Civita P
    Health Econ; 2008 Dec; 17(12):1363-77. PubMed ID: 18189227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quitters can be winners.
    Prather E
    Tex Med; 2006 Nov; 102(11):45-7. PubMed ID: 17304906
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?
    Menzin J; Lines LM; Marton J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):257-64. PubMed ID: 19527098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An appraisal of smoking cessation aids.
    Mundey K
    Curr Opin Pulm Med; 2009 Mar; 15(2):105-12. PubMed ID: 19532024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
    Thavorn K; Chaiyakunapruk N
    Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.